Trials / Completed
CompletedNCT00578695
THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 652 (actual)
- Sponsor
- CardioKine Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lixivaptan | Oral Capsule |
| DRUG | Placebo | Oral Capsule |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2010-06-01
- First posted
- 2007-12-21
- Last updated
- 2011-06-28
Locations
287 sites across 15 countries: United States, Argentina, Canada, Chile, Czechia, Germany, India, Israel, Italy, Poland, Romania, Russia, Slovakia, Spain, Switzerland
Source: ClinicalTrials.gov record NCT00578695. Inclusion in this directory is not an endorsement.